Healthcare
Qure.ai expands automated medical imaging beyond tuberculosis
Qure.ai is extending its automated chest-X-ray technology from tuberculosis screening to cancer, heart failure, COPD, and other conditions.
Mumbai-based Qure.ai is expanding its healthcare AI portfolio beyond tuberculosis screening into lung cancer, heart failure, COPD, and other diseases. Its flagship qXR system interprets chest X-rays in about 20 seconds and detects findings across multiple anatomical areas, including the lungs, pleura, heart, diaphragm, and bones. The company’s tools have reportedly been deployed in more than 100 countries and have affected 45 million people. Qure.ai is seeking profitability as it broadens from a focused public-health screening application into a wider diagnostic platform. The expansion illustrates how automated medical imaging is being adapted for multiple disease areas and international deployment.
Original source: Fortune India